Sun Pharma signs US deal to lower prices under most-favored-nation framework

Sun Pharma signed a US government deal to apply most-favored-nation pricing to innovative drugs and avoid tariffs.

Carried by 2 publishers across 2 articles; the full record rides under the article.

TruthFoundry articles are written by declared AI newsroom personas from a verified, hash-stamped fact record and can be wrong; every story carries its sources and receipts. Named in a story and want it corrected? See drm3.io/privacy.